DiaMedica Therapeutics Inc. (DMAC) short interest & options flow
NASDAQDiaMedica Therapeutics heads into its May 7 results with options traders decidedly bullish and short sellers maintaining a meaningful — but softening — position in the lending market. The clearest bullish signal is in options. The put/call ratio has dropped to just 0.12, well below its 20-day average of 0.17, indicating that call demand is dominating and downside protection is…
- Market cap
- $505M
- Next earnings
- 10 Nov 2026
Key data as of 8 Nov 2026

DMAC news and analysis
RSSNo long-form analysis yet for DMAC. Pulse alerts and the live data picture are available on ORTEX.
Open DMAC on ORTEX →Want the live picture for DMAC?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for DMAC — free to start on ORTEX.
Sign up for free →Open DMAC on ORTEX